Randomized controlled trial of fish oil and montelukast and their combination on airway inflammation and hyperpnea-induced bronchoconstriction

PLoS ONE

Volumn 5, Issue 10, 2010, Pages

  Tecklenburg Lund, Sandra ^a,c   Mickleborough, Timothy D ^a   Turner, Louise A ^a   Fly, Alyce D ^a   Stager, Joel M ^a   Montgomery, Gregory S ^b  

^a INDIANA UNIVERSITY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NEBRASKA WESLEYAN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11 EPIPROSTAGLANDIN F2 ALPHA; DOCOSAHEXAENOIC ACID; EPOXYICOSATRIENOIC ACID; FISH OIL; MONTELUKAST; NITRIC OXIDE; PEPTIDOLEUKOTRIENE; PLACEBO; ACETIC ACID DERIVATIVE; ANTIASTHMATIC AGENT; QUINOLINE DERIVATIVE;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; BRONCHOSPASM; CLINICAL ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE MARKER; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG POTENTIATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HYPERPNEA; MALE; MONOTHERAPY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PH; PROSTAGLANDIN URINE LEVEL; RANDOMIZED CONTROLLED TRIAL; ADOLESCENT; BREATH ANALYSIS; BRONCHITIS; DRUG EFFECT; EXHALATION; LUNG FUNCTION TEST; PATHOPHYSIOLOGY;

ACETATES; ADOLESCENT; ADULT; ANTI-ASTHMATIC AGENTS; BREATH TESTS; BRONCHITIS; BRONCHOCONSTRICTION; DOUBLE-BLIND METHOD; EXHALATION; FEMALE; FISH OILS; HUMANS; MALE; QUINOLINES; RESPIRATORY FUNCTION TESTS;

EID: 78149452849     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0013487     Document Type: Article

References (59)

1. Anderson SD, Kippelen P (2005) Exercise-induced Bronchoconstriction: Pathogenesis. Curr Allergy Asthma Rep 5: 116-122.
2. O'Byrne PM, Gauvreau GM, Brannan JD (2009) Provoked models of asthma: what have we learnt? Clin Exp Allergy 39: 181-192.
3. Lund TK, Pedersen L, Anderson SD, Sverrild A, Backer V (2009) Are asthmalike symptoms in elite athletes associated with classical features of asthma? Br J Sports Med 43: 1131-1135.
4. Hallstrand TS, Moody MW, Wurfel MM, Schwartz LB, Henderson WR Jr., et al. (2005) Inflammatory Basis of Exercise-induced Bronchoconstriction. Am J Respir Crit Care Med 172: 679-686.
5. Dahlen SE, Hedqvist P, Hammarstrom S, Samuelsson B (1980) Leukotrienes are potent constrictors of human bronchi. Nature 288: 484-486.
6. Weiss JW, Drazen JM, Coles N, McFadden ER, Jr., Weller PF, et al. (1982) Bronchoconstrictor effects of leukotriene C in humans. Science 216: 196-198.
7. Holgate ST, Peters-Golden M, Panettieri RA, Henderson WR, Jr. (2003) Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling. J Allergy Clin Immunol 111: S18-S34; discussion S34-S16.
8. Drazen JM (2002) Anti-leukotrienes as novel anti-inflammatory treatments in asthma. Adv Exp Med Biol 507: 217-221.
9. Finnerty JP, Wood-Baker R, Thomson H, Holgate ST (1992) Role of leukotrienes in exercise-induced asthma. Inhibitory effect of ICI 204219, a potent leukotriene D4 receptor antagonist. Am Rev Respir Dis 145: 746-749.
10. Leff JA, Busse WW, Pearlman D, Bronsky EA, Kemp J, et al. (1998) Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction. N Engl J Med 339: 147-152.
11. Pearlman DS, van Adelsberg J, Philip G, Tilles SA, Busse W, et al. (2006) Onset and duration of protection against exercise-induced bronchoconstriction by a single oral dose of montelukast. Ann Allergy Asthma Immunol 97: 98-104.
12. Philip G, Villaran C, Pearlman DS, Loeys T, Dass SB, et al. (2007) Protection against exercise-induced bronchoconstriction two hours after a single oral dose of montelukast. J Asthma 44: 213-217.
13. Rundell KW, Spiering BA, Baumann JM, Evans TM (2005) Effects of montelukast on airway narrowing from eucapnic voluntary hyperventilation and cold air exercise. Br J Sports Med 39: 232-236.
14. Dahlen B, Roquet A, Inman MD, Karlsson O, Naya I, et al. (2002) Influence of zafirlukast and loratadine on exercise-induced bronchoconstriction. J Allergy Clin Immunol 109: 789-793.
15. Hallstrand TS, Henderson WR, Jr. (2009) Role of leukotrienes in exerciseinduced bronchoconstriction. Curr Allergy Asthma Rep 9: 18-25.
16. Mickleborough TD (2008) A nutritional approach to managing exercise-induced asthma. Exerc Sport Sci Rev 36: 135-144.
17. Reisman J, Schachter HM, Dales RE, Tran K, Kourad K, et al. (2006) Treating asthma with omega-3 fatty acids: where is the evidence? A systematic review. BMC Complement Altern Med 6: 26.
18. Mickleborough TD, Lindley MR, Ionescu AA, Fly AD (2006) Protective effect of fish oil supplementation on exercise-induced bronchoconstriction in asthma. Chest 29: 39-49.
19. Mickleborough TD, Murray RL, Ionescu AA, Lindley MR (2003) Fish Oil Supplementation Reduces Severity of Exercise-induced Bronchoconstriction in Elite Athletes. Am J Respir Crit Care Med 168: 1181-1189.
20. Lee TH, Hoover RL, Williams JD, Sperling RI, Ravalese J, 3rd, et al. (1985) Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N Engl J Med 312: 1217-1224.
21. Thien FC, Hallsworth MP, Soh C, Lee TH (1993) Effects of exogenous eicosapentaenoic acid on generation of leukotriene C4 and leukotriene C5 by calcium ionophore-activated human eosinophils in vitro. J Immunol 150: 3546-3552.
22. Gorjao R, Verlengia R, Lima TM, Soriano FG, Boaventura MF, et al. (2006) Effect of docosahexaenoic acid-rich fish oil supplementation on human leukocyte function. Clin Nutr 25: 923-938.
23. Weldon SM, Mullen AC, Loscher CE, Hurley LA, Roche HM (2007) Docosahexaenoic acid induces an anti-inflammatory profile in lipopolysaccharide- stimulated human THP-1 macrophages more effectively than eicosapentaenoic acid. J Nutr Biochem 18: 250-258.
24. O'Byrne PM, Gauvreau GM, Murphy DM (2009) Efficacy of leukotriene receptor antagonists and synthesis inhibitors in asthma. J Allergy Clin Immunol 124: 397-403.
25. Kippelen P, Larsson J, Anderson SD, Brannan JD, Delin I, et al. (2010) Acute effects of beclomethasone on hyperpnea-induced bronchoconstriction. Med Sci Sports Exerc 42: 273-280.
26. Anderson SD, Argyros GJ, Magnussen H, Holzer K (2001) Provocation by eucapnic voluntary hyperpnoea to identify exercise induced bronchoconstriction. Br J Sports Med 35: 344-347.
27. Brummel NE, Mastronarde JG, Rittinger D, Philips G, Parsons JP (2009) The clinical utility of eucapnic voluntary hyperventilation testing for the diagnosis of exercise-induced bronchospasm. J Asthma 46: 683-686.
28. (1995) American Thoracic Society Standardization of spirometry-1994 update. Am J Respir Crit Care Med 152: 1107-1136.
29. (1999) Recommendations for standardized procedures for the on-line and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 160: 2104-2117.
30. Horvath I, Hunt J, Barnes PJ, Alving K, Antczak A, et al. (2005) Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J 26: 523-548.
31. Koczulla R, Dragonieri S, Schot R, Bals R, Gauw SA, et al. (2009) Comparison of exhaled breath condensate pH using two commercially available devices in healthy controls, asthma and COPD patients. Respir Res 10: 78.
32. Willett WC, Sampson L, Stampfer MJ, Rosner B, Bain C, et al. (1985) Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 122: 51-65.
33. Tecklenburg SL, Mickleborough TD, Fly AD, Bai Y, Stager JM (2007) Ascorbic acid supplementation attenuates exercise-induced bronchoconstriction in patients with asthma. Respir Med (In press).
34. Rundell KW, Im J, Mayers LB, Wilber RL, Szmedra L, et al. (2001) Selfreported symptoms and exercise-induced asthma in the elite athlete. Med Sci Sports Exerc 33: 208-213.
35. Parsons JP (2009) Exercise-induced bronchospasm: symptoms are not enough. Expert Rev Clin Immunol 5: 357-359.
36. Hunt JF, Fang K, Malik R, Snyder A, Malhotra N, et al. (2000) Endogenous airway acidification. Implications for asthma pathophysiology. Am J Respir Crit Care Med 161: 694-699.
37. Accordino R, Visentin A, Bordin A, Ferrazzoni S, Marian E, et al. (2008) Longterm repeatability of exhaled breath condensate pH in asthma. Respir Med 102: 377-381.
38. Montuschi P, Barnes PJ (2002) Exhaled leukotrienes and prostaglandins in asthma. J Allergy Clin Immunol 109: 615-620.
39. ElHalawani SM, Ly NT, Mahon RT, Amundson DE (2003) Exhaled nitric oxide as a predictor of exercise-induced bronchoconstriction. Chest 124: 639-643.
40. Kanazawa H, Hirata K, Yoshikawa J (2000) Role of endogenous nitric oxide in exercise-induced airway narrowing in patients with bronchial asthma. J Allergy Clin Immunol 106: 1081-1087.
41. Scollo M, Zanconato S, Ongaro R, Zaramella C, Zacchello F, et al. (2000) Exhaled nitric oxide and exercise-induced bronchoconstriction in asthmatic children. Am J Respir Crit Care Med 161: 1047-1050.
42. Ghiro L, Zanconato S, Rampon O, Piovan V, Pasquale MF, et al. (2002) Effect of montelukast added to inhaled corticosteroids on fractional exhaled nitric oxide in asthmatic children. Eur Respir J 20: 630-634.
43. Sandrini A, Ferreira IM, Gutierrez C, Jardim JR, Zamel N, et al. (2003) Effect of montelukast on exhaled nitric oxide and nonvolatile markers of inflammation in mild asthma. Chest 124: 1334-1340.
44. Schubert R, Kitz R, Beermann C, Rose MA, Lieb A, et al. (2009) Effect of n-3 polyunsaturated fatty acids in asthma after low-dose allergen challenge. Int Arch Allergy Immunol 148: 321-329.
45. Grimminger F, Mayer K, Kiss L, Walmrath D, Seeger W (2000) PAF-induced synthesis of tetraenoic and pentaenoic leukotrienes in the isolated rabbit lung. Am J Physiol Lung Cell Mol Physiol 278: L268-L275.
46. Calder PC (2007) Immunomodulation by omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids 77: 327-335.
47. Martin RE (1998) Docosahexaenoic acid decreases phospholipase A2 activity in the neurites/nerve growth cones of PC12 cells. J Neurosci Res 54: 805-813.
48. Lee JY, Zhao L, Youn HS, Weatherill AR, Tapping R, et al. (2004) Saturated fatty acid activates but polyunsaturated fatty acid inhibits Toll-like receptor 2 dimerized with Toll-like receptor 6 or 1. J Biol Chem 279: 16971-16979.
49. Mickleborough TD, Tecklenburg SL, Montgomery GS, Lindley MR (2009) Eicosapentaenoic acid is more effective than docosahexaenoic acid in inhibiting proinflammatory mediator production and transcription from LPS-induced human asthmatic alveolar macrophage cells. Clin Nutr 28: 71-77.
50. Mickleborough TD, Lindley MR, Ray S (2005) Dietary salt, airway inflammation, and diffusion capacity in exercise-induced asthma. Med Sci Sports Exerc 37: 904-914.
51. Duong M, Subbarao P, Adelroth E, Obminski G, Strinich T, et al. (2008) Sputum eosinophils and the response of exercise-induced bronchoconstriction to corticosteroid in asthma. Chest 133: 404-411.
52. Hallstrand TS, Chi EY, Singer AG, Gelb MH, Henderson WR, Jr. (2007) Secreted phospholipase A2 group X overexpression in asthma and bronchial hyperresponsiveness. Am J Respir Crit Care Med 176: 1072-1078.
53. O'Byrne PM (2000) Leukotriene bronchoconstriction induced by allergen and exercise. Am J Respir Crit Care Med 161: S68-S72.
54. Beasley CR, Robinson C, Featherstone RL, Varley JG, Hardy CC, et al. (1987) 9 alpha,11 beta-prostaglandin F2, a novel metabolite of prostaglandin D2 is a potent contractile agonist of human and guinea pig airways. J Clin Invest 79: 978-983.
55. Dahlen SE, Kumlin M (2004) Monitoring mast cell activation by prostaglandin D(2) in vivo. Thorax 59: 453-455.
56. O'Sullivan S, Roquet A, Dahlen B, Dahlen S, Kumlin M (1998) Urinary excretion of inflammatory mediators during allergen-induced early and late phase asthmatic reactions. Clin Exp Allergy 28: 1332-1339.
57. O'Sullivan S, Roquet A, Dahlen B, Larsen F, Eklund A, et al. (1998) Evidence for mast cell activation during exercise-induced bronchoconstriction. Eur Respir J 12: 345-350.
58. Brannan JD, Gulliksson M, Anderson SD, Chew N, Kumlin M (2003) Evidence of mast cell activation and leukotriene release after mannitol inhalation. Eur Respir J 22: 491-496.
59. Calder PC (2009) Polyunsaturated fatty acids and inflammatory processes: New twists in an old tale. Biochimie 91: 791-795.